New: Introducing the Finviz Crypto Map

Learn More
Last Close
Aug 07 04:00PM ET
12.16
Dollar change
-0.90
Percentage change
-6.89
%
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand19.92M Perf Week-19.20%
Market Cap242.27M Forward P/E- EPS next Y- Insider Trans- Shs Float16.00M Perf Month-
Enterprise Value- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-
Income- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-
Sales- P/B- EPS next Y- ROA- Short Interest- Perf YTD-19.20%
Book/sh- P/C- EPS next 5Y- ROE- 52W High17.94 -32.22% Perf Year-
Cash/sh- P/FCF- EPS past 3/5Y- - ROIC- 52W Low13.01 -6.53% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility8.83% - Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)1.53 Perf 10Y-
Dividend Ex-Date- Quick Ratio- Sales Y/Y TTM- Profit Margin- RSI (14)- Recom-
Dividend Gr. 3/5Y- - Current Ratio- EPS Q/Q- SMA20-12.04% Beta- Target Price-
Payout- Debt/Eq- Sales Q/Q- SMA50-12.04% Rel Volume0.51 Prev Close13.06
Employees56 LT Debt/Eq- Earnings- SMA200-12.04% Avg Volume597.50K Price12.16
IPOJul 31, 2025 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume334,488 Change-6.89%
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care - preoperative planning, implant design and procedural efficiency - to benefit each stakeholder in the care chain. Our ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gilde Healthcare Holding B.V.10% OwnerAug 01 '25Buy15.00100,0001,500,0002,380,482Aug 05 06:37 PM
Carusi Michael ADirectorAug 01 '25Buy15.00266,6663,999,9901,885,136Aug 05 04:05 PM
Buchholz RichardDirectorAug 01 '25Buy15.005,00075,00012,666Aug 05 04:05 PM
LSV Associates II, LLCFormer 10% OwnerAug 01 '25Buy15.00266,6663,999,9901,885,136Aug 05 04:05 PM
Pardo Geoffrey BDirectorAug 01 '25Buy15.00100,0001,500,0002,380,482Aug 05 04:05 PM
Tansey Casey MDirectorAug 01 '25Buy15.0040,000600,00047,666Aug 05 04:05 PM
Points Jeffrey S.CHIEF FINANCIAL OFFICERAug 01 '25Buy15.005075050Aug 05 04:05 PM
Last Close
Aug 07 04:00PM ET
77.05
Dollar change
-1.40
Percentage change
-1.78
%
INSP Inspire Medical Systems Inc daily Stock Chart
Index- P/E44.64 EPS (ttm)1.73 Insider Own5.61% Shs Outstand29.57M Perf Week-38.13%
Market Cap2.28B Forward P/E46.83 EPS next Y1.65 Insider Trans-2.04% Shs Float27.91M Perf Month-42.69%
Enterprise Value2.01B PEG2.65 EPS next Q-0.16 Inst Own110.97% Short Float11.79% Perf Quarter-50.77%
Income53.12M P/S2.65 EPS this Y-34.29% Inst Trans1.41% Short Ratio4.05 Perf Half Y-59.87%
Sales861.31M P/B3.36 EPS next Y43.06% ROA6.94% Short Interest3.29M Perf YTD-58.44%
Book/sh22.92 P/C7.57 EPS next 5Y16.83% ROE8.07% 52W High225.00 -65.76% Perf Year-47.05%
Cash/sh10.17 P/FCF26.81 EPS past 3/5Y- - ROIC7.50% 52W Low73.92 4.23% Perf 3Y-64.47%
Dividend Est.- EV/EBITDA38.53 Sales past 3/5Y50.95% 57.80% Gross Margin84.47% Volatility9.31% 5.17% Perf 5Y-22.45%
Dividend TTM- EV/Sales2.33 EPS Y/Y TTM785.52% Oper. Margin4.81% ATR (14)8.49 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.84 Sales Y/Y TTM22.05% Profit Margin6.17% RSI (14)18.48 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio6.14 EPS Q/Q-137.80% SMA20-36.58% Beta1.20 Target Price152.60
Payout0.00% Debt/Eq0.05 Sales Q/Q10.82% SMA50-39.98% Rel Volume2.61 Prev Close78.45
Employees1246 LT Debt/Eq0.05 EarningsAug 04 AMC SMA200-53.22% Avg Volume811.82K Price77.05
IPOMay 03, 2018 Option/ShortYes / Yes EPS/Sales Surpr.122.88% 1.31% Trades Volume2,061,604 Change-1.78%
Date Action Analyst Rating Change Price Target Change
Aug-05-25Downgrade Truist Buy → Hold $125
Aug-05-25Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Aug-05-25Downgrade JP Morgan Overweight → Neutral $110
Nov-20-24Upgrade BofA Securities Neutral → Buy $220 → $255
May-08-24Downgrade BofA Securities Buy → Neutral $265 → $225
Apr-19-24Initiated RBC Capital Mkts Outperform $285
Mar-19-24Initiated Morgan Stanley Overweight $250
Feb-06-24Resumed KeyBanc Capital Markets Overweight $278
Jan-19-24Initiated Jefferies Buy $245
Jan-02-24Downgrade Stifel Buy → Hold $210
Aug-07-25 01:01PM
Aug-06-25 10:18PM
12:23PM
Aug-05-25 12:41PM
11:38AM
09:37AM Loading…
09:37AM
09:35AM
05:49AM
03:05AM
Aug-04-25 06:30PM
06:05PM
05:05PM
04:31PM
04:02PM
Aug-02-25 11:02PM
08:50AM Loading…
Aug-01-25 08:50AM
07:40AM
Jul-31-25 10:00AM
07:32AM
Jul-30-25 01:09PM
Jul-28-25 10:00AM
Jul-16-25 08:50AM
12:06AM
Jul-15-25 08:50AM
Jul-07-25 10:14AM
08:00AM
Jun-13-25 11:21AM
08:27AM
Jun-12-25 12:59PM
Jun-11-25 09:51AM
09:02AM Loading…
Jun-06-25 09:02AM
Jun-04-25 11:30AM
Jun-03-25 08:00AM
Jun-02-25 10:23AM
May-30-25 08:00AM
May-29-25 08:47AM
May-27-25 08:15AM
May-26-25 08:30AM
08:30AM
May-22-25 06:46AM
06:38AM
May-21-25 07:49AM
May-20-25 08:53AM
May-15-25 08:55AM
May-08-25 09:50AM
May-07-25 12:00PM
09:55AM
May-06-25 12:29PM
08:36AM
03:08AM
May-05-25 06:54PM
05:10PM
04:02PM
May-02-25 10:56AM
09:20AM
Apr-29-25 08:00AM
Apr-21-25 08:00AM
Apr-01-25 08:00AM
Mar-12-25 11:30AM
Mar-11-25 05:04AM
Mar-06-25 08:00AM
Mar-04-25 11:53PM
08:06AM
Feb-28-25 04:03AM
Feb-25-25 02:53PM
09:50AM
Feb-12-25 09:45AM
Feb-11-25 08:40AM
07:01AM
02:08AM
Feb-10-25 05:30PM
05:10PM
04:19PM
04:02PM
Feb-09-25 08:02AM
Feb-07-25 07:07AM
Feb-05-25 09:15AM
Feb-03-25 10:00AM
Jan-13-25 06:45AM
Jan-09-25 07:30AM
Jan-07-25 09:50AM
08:00AM
Jan-06-25 08:15AM
Dec-30-24 08:00AM
Dec-23-24 02:25PM
Dec-05-24 12:12PM
Dec-04-24 11:30AM
Nov-20-24 02:08PM
Nov-19-24 08:00AM
Nov-18-24 10:00AM
Nov-15-24 08:00AM
Nov-11-24 06:45AM
Nov-06-24 08:00AM
06:31AM
Nov-05-24 02:09AM
Nov-04-24 06:30PM
05:20PM
04:02PM
Oct-30-24 09:15AM
08:00AM
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
mcCormick ShawnDirectorJun 04 '25Option Exercise16.004,00064,00028,046Jun 06 06:06 PM
Rondoni JohnSee RemarksMay 19 '25Sale149.381,734259,02513,766May 21 04:05 PM
JOHN RONDONIOfficerMay 19 '25Proposed Sale149.381,734259,025May 19 04:01 PM
mcCormick ShawnDirectorMay 02 '25Sale160.0036057,60024,046May 05 07:31 PM
SHAWN T MCCORMICK DirectorMay 02 '25Proposed Sale157.9036056,844May 02 04:23 PM
Ban RandySee RemarksMar 03 '25Sale185.843,947733,4967,259Mar 05 04:47 PM
Rondoni JohnChief Technology OfficerMar 03 '25Sale185.602,287424,46715,500Mar 05 04:46 PM
JOHN RONDONIOfficerMar 03 '25Proposed Sale185.602,287424,467Mar 03 04:27 PM
RANDALL BAN OfficerFeb 28 '25Proposed Sale184.023,947726,327Feb 28 04:18 PM
Ban RandySee RemarksFeb 13 '25Option Exercise67.6325,0001,690,75032,843Feb 18 06:44 PM
Ban RandySee RemarksFeb 13 '25Sale183.5025,5844,694,7667,259Feb 18 06:44 PM
Rondoni JohnChief Technology OfficerFeb 11 '25Sale170.4958399,39610,424Feb 13 08:14 PM
RANDALL BAN OfficerFeb 13 '25Proposed Sale187.0125,5844,784,464Feb 13 04:30 PM
JOHN RONDONIOfficerFeb 11 '25Proposed Sale170.4958399,396Feb 11 04:01 PM
Rondoni JohnChief Technology OfficerJan 07 '25Sale215.005812,47011,322Jan 10 04:05 PM
JOHN RONDONIOfficerJan 07 '25Proposed Sale215.005812,470Jan 07 04:02 PM
Rondoni JohnChief Technology OfficerNov 01 '24Option Exercise61.388,703534,21920,051Nov 05 04:01 PM
Rondoni JohnChief Technology OfficerNov 01 '24Sale193.478,7031,683,73111,348Nov 05 04:01 PM
JOHN RONDONIOfficerNov 01 '24Proposed Sale193.468,7031,683,723Nov 01 04:47 PM
Ebeling PhilipOfficerSep 11 '24Proposed Sale247.285,4531,348,445Sep 11 06:01 PM
McCormick ShawnDirectorSep 09 '24Sale220.00800176,00023,140Sep 11 05:02 PM
Rondoni JohnChief Technology OfficerSep 09 '24Sale215.00316,66511,348Sep 11 05:01 PM
SHAWN T MCCORMICKDirectorSep 09 '24Proposed Sale220.00800176,000Sep 09 04:09 PM
JOHN RONDONIOfficerSep 09 '24Proposed Sale215.00316,665Sep 09 04:08 PM
Rondoni JohnChief Technology OfficerAug 22 '24Option Exercise71.005,000355,00016,379Aug 23 04:09 PM
Rondoni JohnChief Technology OfficerAug 22 '24Sale189.835,000949,14311,379Aug 23 04:09 PM
JOHN RONDONIOfficerAug 22 '24Proposed Sale189.825,000949,100Aug 22 04:22 PM
Ban RandyChief Commercial OfficerAug 15 '24Option Exercise42.1516,139680,25919,195Aug 19 08:14 PM
Ban RandyChief Commercial OfficerAug 16 '24Option Exercise42.154,861204,8917,917Aug 19 08:14 PM
Ban RandyChief Commercial OfficerAug 15 '24Sale193.1016,1393,116,3973,056Aug 19 08:14 PM
Ban RandyChief Commercial OfficerAug 16 '24Sale188.554,861916,5493,056Aug 19 08:14 PM
RANDALL A BANOfficerAug 16 '24Proposed Sale188.554,861916,560Aug 16 04:34 PM
Ebeling PhilipOfficerAug 15 '24Proposed Sale194.8443,9018,553,615Aug 15 05:36 PM
McCormick ShawnDirectorAug 14 '24Option Exercise0.948,5378,02523,940Aug 15 04:19 PM
RANDALL A BANOfficerAug 15 '24Proposed Sale193.1016,1393,116,380Aug 15 04:13 PM
Ebeling PhilipOfficerAug 14 '24Proposed Sale190.034,596873,393Aug 14 04:50 PM